Hexagon Nutrition IPO Opens: Market Sentiment and Investment Analysis

Hexagon Nutrition IPO Opens: Market Sentiment and Investment Analysis Photo by ehnmark on Openverse

Public Subscription Begins

Hexagon Nutrition Ltd launched its initial public offering (IPO) on June 5, initiating a bidding window that remains open until June 9. The Rs 139-crore public issue, featuring a price band of Rs 42-45 per equity share, has already attracted significant attention from retail investors on its first day of trading.

Context and Company Background

Founded in 1993, Hexagon Nutrition began as a micronutrient formulations business before diversifying into a broad spectrum of branded nutrition products. Today, the company operates in over 75 countries, offering a portfolio that includes micronutrient premixes, therapeutic nutrition, and clinical wellness products under brands such as Pentasure, Obesigo, and Pediagold.

Financial Performance and Market Valuation

The company has demonstrated robust financial growth, reporting a Compound Annual Growth Rate (CAGR) for Revenue, EBITDA, and Profit After Tax (PAT) of 8.0%, 35.1%, and 104.6% respectively between FY23 and FY25. At the upper price band of Rs 45, the IPO is valued at a Price-to-Earnings (P/E) multiple of 15.3x based on annualized 9MFY26 earnings.

Expert Perspectives

Brokerage firm SBI Securities has issued a “Subscribe” recommendation for the IPO, citing a long-term investment horizon. Analysts point to the company’s diversified business model and strong positioning within the structurally growing wellness industry as primary drivers for future performance. Ahead of the public opening, the company successfully raised Rs 41.66 crore from anchor investors, including Bandhan Small Cap Fund, at the upper price band of Rs 45 per share.

Grey Market Sentiment

Market enthusiasm is reflected in the grey market, where Hexagon Nutrition shares are currently commanding a premium of Rs 12 over the issue price. This 26.67% premium suggests an estimated listing price of approximately Rs 57 per share, signaling positive investor appetite for the company’s market debut.

Strategic Implications

The primary goal of this listing is to enhance the company’s visibility, strengthen brand recognition, and provide liquidity to existing shareholders. As the IPO is an offer-for-sale (OFS) of over 3.08 crore equity shares by promoters, the proceeds will not go toward company capital expenditure but rather facilitate shareholder exit strategies. Investors should monitor the final subscription numbers closely as the June 9 closing date approaches. Following the closure, the company is expected to list on the stock exchanges on June 12, marking a significant milestone in its three-decade history.

Leave a Reply

Your email address will not be published. Required fields are marked *